FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and pharmaceutical industry. More specifically, an infusion solution for intravenous administration and use thereof as a plasma-substituting solution are disclosed. Said infusion solution has osmolarity of 266–298 mmol/l and comprises: 5.5–6.5 g/l of sodium fumarate; 4.5–4.8 g/l of sodium chloride; 0.075–0.125 g/l of magnesium chloride (anhydrous); 0.55–0.65 g/l potassium asparaginate; water for injection (up to 1 l).
EFFECT: group of inventions provides a balanced ionic composition for infusions having cardiotonic, antihypoxic and antioxidant action.
2 cl, 6 ex, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| POLYFUNCTIONAL BLOOD SUBSTITUTE FOR TREATMENT OF BLOOD LOSS AND SHOCK | 1998 |
|
RU2136291C1 |
| ARTIFICIAL PLASMA EXTENDER | 2014 |
|
RU2582219C2 |
| POLYFUNCTIONAL BLOOD SUBSTITUTE | 2003 |
|
RU2245150C1 |
| PREPARATION OF HEMODYNAMIC ACTION WITH THE FUNCTION FOR NORMALIZATION OF ACID-BASE BALANCE AND ELECTROLYTE ONE | 2000 |
|
RU2185173C2 |
| ANTIHYPOXIC MEDICINAL AGENT | 2001 |
|
RU2189813C1 |
| MULTICOMPONENT INFUSION SOLUTION OF ELECTROLYTES IN COMBINATION WITH BIOLOGICALLY ACTIVE COMPONENTS FOR INTRAVENOUS ADMINISTRATION | 2022 |
|
RU2796724C1 |
| PLASMA-SUBSTITUTING SOLUTION "MAФУСOЛ" FOR ANTISHOCK THERAPY | 1984 |
|
SU1630043A1 |
| ISOTONIC INFUSION SOLUTION | 2020 |
|
RU2744331C1 |
| BALANCED INFUSION SOLUTION | 2014 |
|
RU2549448C1 |
| METHOD FOR EARLY THERAPY OF HEMORRHAGIC SHOCK OF II, III DEGREE | 2004 |
|
RU2258529C1 |
